Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 7.

Codó, P; Weller, M; Kaulich, K; Schraivogel, D; Silginer, M; Reifenberger, G; Meister, G; Roth, P (2016). Control of glioma cell migration and invasiveness by GDF-15. OncoTarget, 7(7):7732-7746.

Silginer, M; Burghardt, I; Gramatzki, D; Bunse, L; Leske, H; Rushing, E J; Hao, N; Platten, M; Weller, M; Roth, P (2016). The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway. Oncogene, 35(25):3260-3271.

Silginer, M; Weller, M; Ziegler, U; Roth, P (2014). Integrin inhibition promotes atypical anoikis in glioma cells. Cell Death and Disease, 5:e1012.

Happold, C; Roth, P; Silginer, M; Florea, A M; Lamszus, K; Frei, K; Deenen, R; Reifenberger, G; Weller, M (2014). Interferon-β induces loss of spherogenicity and overcomes therapy resistance of glioblastoma stem cells. Molecular Cancer Therapeutics, 13(4):948-961.

Roth, P; Silginer, M; Goodman, S L; Hasenbach, K; Thies, S; Maurer, G; Schraml, P; Tabatabai, G; Moch, H; Tritschler, I; Weller, M (2013). Integrin control of the transforming growth factor-β pathway in glioblastoma. Brain, 136(2):564-576.

Silginer, M. Integrin inhibition interferes with TGF-beta signaling in malignant glioma cells. 2013, University of Zurich, Faculty of Medicine.

Happold, C; Roth, P; Wick, W; Schmidt, N; Florea, A M; Silginer, M; Reifenberger, G; Weller, M (2012). Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells. Journal of Neurochemistry, 122(2):444-455.

This list was generated on Sat Sep 23 18:31:03 2017 CEST.